Lissoni P, Malugani F, Casu M, Bukovec R, Egardi R, Bordin V, Fumagalli E, Mengo S, Gardani G. Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients.
Neuro Endocrinol Lett. 2002 Feb;
23(1): 61-63
Cardinali D, Gvozdenovich E, Kaplan M, Fainstein I, Shifis H, Pérez Lloret S, Albornoz L, Negri A. A double blind-placebo controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly.
Neuro Endocrinol Lett. 2002 Feb;
23(1): 55-60
Cano P, Cardinali D, Chacon F, Reyes Toso C, Esquifino A. Nighttime changes in norepinephrine and melatonin content and serotonin turnover in pineal glands of young and old rats injected with Freund's adjuvant.
Neuro Endocrinol Lett. 2002 Feb;
23(1): 49-53
Kariyawasam S, Zaw F, Handley S. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
Neuro Endocrinol Lett. 2002 Feb;
23(1): 45-48
Erkut Z, Gabreëls B, Eikelenboom J, van Leeuwen F, Swaab D. Glucocorticoid treatment is associated with decreased expression of processed AVP but not of proAVP, neurophysin or oxytocin in the human hypothalamus: are PC1 and PC2 involved?
Neuro Endocrinol Lett. 2002 Feb;
23(1): 33-44
De Bortoli M, Garraza M, Aguado L. Involvement of beta-adrenoceptors in a central regulation of the ovarian progesterone release in rats.
Neuro Endocrinol Lett. 2002 Feb;
23(1): 27-31
Stefano G, Zhu W, Cadet P, Mantione K, Bilfinger T, Bianchi E, Guarna M. A hormonal role for endogenous opiate alkaloids: vascular tissues.
Neuro Endocrinol Lett. 2002 Feb;
23(1): 21-26